← back to search

Chengjie Xiong

Mallinckrodt (United States) · CN
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Health, Environment, Cognitive Aging.
h-index
62
citations
16,699
works
346
NIH funding
primary concept
Medicine
email

Recent publications

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
The Lancet Neurology 2025cited by 34position: middledoi
Cognitive reserve influences symptom onset and longitudinal decline in Dominantly Inherited Alzheimer's Disease
Alzheimer s & Dementia 2024cited by 1position: middledoi
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
Nature Neuroscience 2023cited by 45position: middledoi
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 23position: middledoi
Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid
Nature 2022cited by 313position: middledoi
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition
Alzheimer s & Dementia 2022cited by 83position: middledoi
Autosomal dominant and sporadic late onset Alzheimer's disease share a common<i>in vivo</i>pathophysiology
Brain 2022cited by 58position: middledoi
A real-time 3D electromagnetic navigation system for percutaneous transforaminal endoscopic discectomy in patients with lumbar disc herniation: a retrospective study
BMC Musculoskeletal Disorders 2022cited by 24position: lastdoi
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
Alzheimer s & Dementia Translational Research & Clinical Interventions 2022cited by 20position: lastdoi
Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials
Frontiers in Aging Neuroscience 2022cited by 14position: middledoi
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Nature Medicine 2021cited by 362position: middledoi
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Neurology Genetics 2021cited by 53position: middledoi
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease
Brain Connectivity 2021cited by 27position: middledoi
A Computational Monte Carlo Simulation Strategy to Determine the Temporal Ordering of Abnormal Age Onset Among Biomarkers of Alzheimer's Disease
IEEE/ACM Transactions on Computational Biology and Bioinformatics 2021cited by 19position: middledoi
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
Nature Medicine 2020cited by 655position: middledoi
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
Neurobiology of Disease 2020cited by 60position: middledoi
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations
Nature Neuroscience 2019cited by 368position: middledoi
Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers
Brain 2019cited by 182position: middledoi
Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2019cited by 136position: middledoi
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Neurology 2018cited by 317position: middledoi
Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
NeuroImage Clinical 2018cited by 127position: middledoi
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing
Brain 2018cited by 105position: middledoi
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Alzheimer s & Dementia 2016cited by 301position: lastdoi
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
PLoS ONE 2016cited by 55position: middledoi
Factors Associated With the Onset and Persistence of Post–Lumbar Puncture Headache
JAMA Neurology 2015cited by 92position: middledoi
Functional Connectivity in Autosomal Dominant and Late-Onset Alzheimer Disease
JAMA Neurology 2014cited by 135position: middledoi
Developing an international network for Alzheimer’s research: the Dominantly Inherited Alzheimer Network
Clinical Investigation 2012cited by 217position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tammie L.S. Benzinger · Cornell University4 papers (2016–2024)Randall J. Bateman · Washington Center4 papers (2015–2024)Anne M. Fagan · Indiana University Bloomington3 papers (2015–2021)John C. Morris · Resonance Research (United States)3 papers (2015–2021)Eric McDade · Hope Center for Neurological Disorders3 papers (2015–2024)Stephen Salloway · Brown University2 papers (2015–2016)Yi Su · Nanjing University of Aeronautics and Astronautics2 papers (2018–2021)Carlos Cruchaga · Stanford University2 papers (2021–2024)Lon S. Schneider · University of Southern California2 papers (2016–2022)Jason Hassenstab · John Wiley & Sons (United States)2 papers (2016–2024)Martin R. Farlow · Harvard University2 papers (2015–2016)Guoqiao Wang · California State University, Long Beach2 papers (2016–2022)Andrew J. Aschenbrenner · Neurology, Inc2 papers (2022–2024)Brian A. Gordon · Alzheimer’s Disease Neuroimaging Initiative2 papers (2018–2024)Jorge J. Llibre‐Guerra · Università della Svizzera italiana2 papers (2021–2024)David B. Clifford · Washington University in St. Louis2 papers (2015–2016) · 1 papers (2024–2024)Chengwei Fu · Guangzhou University of Chinese Medicine1 papers (2022–2022)James M. Noble · Allen Institute for Brain Science1 papers (2015–2015)Alan E. Renton · Icahn School of Medicine at Mount Sinai1 papers (2024–2024)